The vast majority of patients with primary dystonia are adults with focal or segmental distribution of involuntary movements. Although approximately 10% of probands have at least one first-or second-degree relative with dystonia, large families suited for linkage analysis are exceptional.
INTRODUCTION
Dystonia, defined as a syndrome of involuntary, sustained muscle contractions affecting one or more sites of the body, frequently causing twisting and repetitive movements or abnormal postures, is a genetically and clinically heterogeneous movement disorder (1) . Dystonias are categorized by etiology (primary, secondary, dystonia-plus, and heredodegenerative diseases with dystonia), age of onset (<20 or >20 years), and anatomical distribution (focal, segmental, multifocal, hemi-dystonia, or generalized) (1, 2) . Most cases of primary dystonia begin in adults and primary adult-onset dystonia is more common in females (2, 3) . Cervical dystonia (CD) or spasmodic torticollis is the most common form of focal dystonia, characterized by involuntary contractions of the neck muscles producing abnormal posturing of the head upon the trunk (4).
In the United States, primary dystonia may be less common among African-Americans than Caucasians (5, 6) . Genetic factors contribute to the pathogenesis of adult-onset primary dystonia since 10% of patients have one or more affected first-or second-degree relatives (2, 7) . Familial and sporadic dystonia appear to share the same genetic underpinnings (8) .
To date, four genes (TOR1A, THAP1, CIZ1, and ANO3) and several additional genetic loci (DYT4, DYT7, DYT13, and DYT21) have been associated with primary dystonia (9) (10) (11) (12) (13) (14) (15) (16) .
Mutations in TOR1A are typically associated with early-onset generalized dystonia, whereas mutations in THAP1 and ANO3 most commonly cause segmental craniocervical dystonia.
Mutations in CIZ1 have only been reported in patients with adult-onset cervical dystonia (12) . In aggregate, these four genes account for less than 5% of adult-onset cases of primary dystonia.
Although adult-onset primary dystonia has a considerable heritable component, penetrance is reduced and the identification of genetic etiologies has been hampered by the availability of large pedigrees that are sufficiently powered for linkage analysis. With the advent of wholeexome sequencing, smaller pedigrees are proving suitable for the identification of sequence variants (SVs) causally associated with dystonia and other movement disorders.
In the present study, we demonstrate that familial adult-onset primary dystonia can result from mutations in GNAL, which encodes guanine nucleotide binding protein, alpha activating activity polypeptide, olfactory type (Gα(olf), Golfalpha), a key player in signal transduction within olfactory neuroepithelium and the basal ganglia (17, 18) .
RESULTS

Linkage analysis and exome sequencing
GNAL mutations were identified in the four independent pedigrees (Fig. 1) . The largest family (A) was employed for linkage analysis and whole-exome sequencing. As previously described (6) , the members of this pedigree reported ages of onset from 45 to 63 years (Table 1 ). All affected subjects in Families A, B, C and D had dystonia and varying degrees of microsmia with otherwise normal neurological examinations. In particular, no subject showed clinical evidence of ataxia, spasticity, oculomotor abnormalities, Parkinsonism, or neuropathy.
Eighteen subjects from Family A were genotyped with the HumanLinkage-24 Bead Chip (Illumina, San Diego, CA, USA). Call rates were over 99.6% for all 18 samples and reproducibility was 100% for 6 samples subjected to technical replication (Supplementary Material, Table S1 ). SNP genotypes were analyzed with Superlink-Online SNP version 1.0 (http://cbl-hap.cs.technion.ac.il/superlink-snp/) (19) using a dominant model with a mutant allele frequency of 0.0001 and penetrance of 0.5 (Supplementary Material, Table S2 ). The highest multi-point LOD score was 1.10. LOD scores of 1 or less were obtained within the DYT7, DYT13 and DYT21 loci.
In-solution whole-exome capture and massively parallel sequencing was performed on two definitely affected and one unaffected subject from Family A using the Agilent SureSelect XT All Exon Kit 51 Mb (Santa Clara, CA, USA). After filtering and elimination of read errors with Sanger sequencing, three SVs were common to the two affected subjects and absent from the unaffected subject. However, only a single SV co-segregated with dystonia in Family A (GNAL; c.682G>T, p.V228F). Table S4 ; Fig. S1 ). This SNP is located near GNAL and within the previously published DYT7 locus on Chr 18p11.2 (14) .
Post hoc linkage analysis of Family
Haplotype analysis of Chr 18p showed that SNPs near GNAL co-segregated with c.682G>T in subjects with dystonia (Fig. S2) . In silico analyses with ClustalW2 (20), Polyphen-2 (21), SIFT (22) and MutationTaster (23) indicated that c.682G>T (p.V228F) altered a highly conserved amino acid and was disease causing (Supplementary Material, Table S5 ).
Mutation screening and in silico analysis
High-resolution melting (HRM) (7, 12) and Sanger sequencing were used for GNAL mutation screening in 760 subjects with mainly CD and 768 neurologically-normal controls 
Role of Gα(olf) in Olfaction
Given the established role of Gα(olf) in olfaction and to investigate the potential utility of olfactory testing as a preclinical diagnostic tool in primary dystonia, Families A, B, C and D were examined with the 40-item University of Pennsylvania Smell Identification Test (24) (UPSIT; Sensonics, Inc., Haddon Heights, NJ) (Supplementary Material, Table S8 ). UPSIT data was analyzed with SAS 9.3 (SAS Institute Inc., Cary, NC). When data from all 4 families was grouped together, differences in mean UPSIT scores ± standard error of the mean (SEM) among manifesting carriers (n = 7, 30.8±3.1), non-manifesting carriers (n = 8, 33.7±2.8) and non-carrier neurologically-normal family members (n = 14, 35.1±3.7) were not significant.
However, an independent one-tailed t-test restricted to data from Family A indicated that manifesting and non-manifesting mutation carriers (n = 6, 25.5±2.9) had lower UPSIT scores than non-carrier neurologically-normal family members (n = 5, 33.0±1.1; p < 0.26).
Relative expression of GNAL using qRT-PCR
GNAL has three isoforms. Isoform 1 (NM_182978.3) is the longest whereas Isoform 2 (NM_001142339.2) is the major isoform (Fig. 2) . Relative expression of Isoforms 1 and 2 was examined in human brain and leukocytes using quantitative RT-PCR (Supplementary Material, Table S9 ). Adult human whole brain total RNA (FirstChoice® Human Brain Reference RNA [1 mg/ml]) was obtained from Ambion (Austin, TX, USA). Fetal human whole brain and adult human cerebral cortex, cerebellum, and substantia nigra total RNA were purchased from Clontech (Mountain View, CA, USA). Striatum total RNA was acquired from Agilent. Overall GNAL expression was highest in striatum and fetal whole brain whereas relative expression of Isoform 2 to Isoform 1 was highest in striatum and cerebral cortex. Suggestive of NMD, overall leukocyte expression of GNAL was reduced in one subject from Family B (c.591dupA). We were unable to detect Isoform 1 in leukocytes. The c.3G>A mutation in Family D had no apparent effect on leukocyte expression of GNAL.
Immunocytochemistry of Gα(olf) in central nervous system
Since previous study of Gα(olf) had focused on the olfactory bulb and striatum, we performed immunocytochemistry to obtain a more complete picture of Gα(olf)'s distribution in the central nervous system. Gα(olf)-immunoreactivity (IR) was present in olfactory bulb, striatum, thalamus, substantia nigra, and cerebellum at P14 and in adult rat brains (Fig. 3) . In cerebellum, Gα(olf)-IR was most prominent in Purkinje cells with weaker IR in granule cells. At P14, Gα(olf)-IR was seen throughput the dendritic arbor of Purkinje cells. However, in adult cerebellum, Gα(olf)-IR was largely restricted to the soma and proximal dendrites of Purkinje cells. In Purkinje cells, Gα(olf) co-localized with CRH-RI/II, but not PMCA4. At P14, Gα(olf)-IR was concentrated in the somas and proximal dendrites of medium spiny and cholinergic neurons within the striatum. In adult brain, more diffuse striatal Gα(olf)-IR was apparent.
Gα(olf)-IR was localized to ChAT-positive in striatal neurons at P14. However, in adult rat brain, Gα(olf)-IR in striatal cholinergic neurons was weak. At P14, Gα(olf)-IR was prominent in both dopaminergic and non-dopaminergic neurons of the substantial nigra. In adult rat brain, Gα(olf)-IR remained robust in TH-positive neurons of the substantia nigra but was less conspicuous in TH-negative neurons.
Gene expression analysis
Given the diverse role of G-proteins in regulating myriad cellular processes, gene expression studies were performed to identify pathways possibly dysregulated by mutant Gα(olf) [p.V228F].
These experiments employed RNA derived from lymphoblastoid cell lines established for 4 affected carriers and 4 non-carriers from Family A. Unpaired t-tests were used to filter significant probes. Probes that were significant at p ≤ 0.05 with a mean fold change ≥ 1.5 were retained for downstream analyses.
In total, 82 genes were up-regulated and 29 were down-regulated (Supplementary Material, Tables S11 and S12; Fig. S3 ). Enrichment analysis of differentially expressed genes was performed with WebGestalt Gene Set Analysis Toolkit 2.0 (http://bioinfo.vanderbilt.edu/webgestalt/) (25) . The differentially expressed gene set was compared to the human genome using the hypergeometric test followed by correction for multiple testing using the Benjamini & Hochberg (BH) method at a significance level of 0.05 (FDR <0.05) (26) . Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were accessed from WebGestalt (27, 28) . Dysregulated cellular networks were examined with Ingenuity Pathway Analysis (IPA; Ingenuity, Redwood City, CA, USA).
Our gene set enrichment identified 15 Tables S14 and S15 ). The top dysregulated networks were involved in cell cycle control, development, cell death, and cellular proliferation ( Table 2) .
DISCUSSION
Previous work from several groups had suggested that a dystonia-associated gene resides on Chr 18p (14, (29) (30) (31) (32) (33) (34) (35) . In 1996, Leube and colleagues reported a large German pedigree with CD and linkage to the region telomeric to D18S1153 on Chr 18p with a maximal LOD score of 3.17 (36) . Follow-up studies narrowed this dystonia locus to a 30 cM region near D18S1098 but also presented evidence of locus heterogeneity in adult-onset CD (14, 37) . More recent work has shed doubt on the DYT7 locus for CD on Chr 18p (38) . Although CD and other forms of adultonset dystonia are genetically heterogeneous, dystonia is a relatively common manifestation of 18p deletion syndrome (MIM 146390) (29, (31) (32) (33) (34) (35) . Dystonia in 18p deletion syndrome can be focal, segmental or generalized. Some subjects with the 18p deletion syndrome also exhibit myoclonus and white matter abnormalities on magnetic resonance imaging of the brain. Nasir et al. identified a Chr 18p 15 Mb deletion that included GNAL in a mother and her son both affected with dystonia (33) . Moreover, linkage to Chr 18p was reported in three brothers with late-onset hand-forearm dystonia (30) . When integrated with previous work, the data reported herein indicates that (1) GNAL is the dystonia-associated gene within the DYT7 locus on Chr 18p, and (2) loss of function mutations in GNAL cause various anatomical distributions of dystonia.
Gα(olf) belongs to a class of GTP-binding proteins (G proteins) which couple G-protein receptors to adenylyl cyclase. Heterotrimeric G protein complexes are composed of three subunits (α, β, and γ). G proteins are categorized into four subfamilies according to their α-subunits (Gαs, Gαi/o, Gαq, and Gα12). Gα(olf) which has 88% amino acid homology to Gαs is considered a member of the Gαs family. Although Gα(olf) was originally discovered in the olfactory neuroepithelium and striatum, it has been identified in pancreatic β-cells, vestibular end organs, testis, spleen, lung and heart (39, 40) . Our immunocytochemical work indicates that Gα(olf) is widely expressed in brain, especially in motor regions that have previously been associated with dystonia.
At the network level, dystonia has been considered a disorder of the (1) basal ganglia, (2) olivocerebellar pathways or (3) their interaction (41) (42) (43) . In dystonic rats, dystonia has been associated with abnormal neurotransmission at the climbing fiber-Purkinje cell synapse (44) .
Climbing fiber activity leads to the release of CRH which facilitates induction of long-term depression at both parallel fiber and climbing fiber synapse (45) . In the striatum, Gα(olf) is upregulated after lesioning the nigrostriatal dopaminergic pathway which contributes to levodopa-induced dyskinesias in models of Parkinson's disease (17) .
Although mutations in GNAL had not previously been associated with olfactory dysfunction in humans, two Iranian families with isolated congenital anosmia showed linkage to 18p11.23-q12.2 (46) . More importantly, mice deficient in Gα(olf) are anosmic (18) . In our study, microsmia was most prominent in those members of African-American Family A also affected with dystonia. However, in the Caucasian families, microsmia was absent or variable in mutation carriers. These data suggest that, like dystonia, the penetrance of olfactory dysfunction may be reduced and dependent on genetic background. In addition, alternate olfactory signaling pathways may compensate for Gα(olf) deficiency given that, in contrast to the Caucasian families, Family A harbored a missense mutation in GNAL.
At the cellular level, some forms of primary dystonia have been characterized as neurodevelopmental disorders and several dystonia associated proteins (THAP1, TAF1 and CIZ1) play important roles at the G 1 -S checkpoint of the cell cycle (2, 10, 12, 47) . Similarly, our gene expression studies of Gα(olf) p.V228F lymphoblastoid cells lines identified dysregulated cellular networks involved in cell cycle, development and gene expression. Given that blockade of dopamine receptors promotes histone H3 phosphorylation through adenosine A2A receptormediated activation of Gα(olf), it is possible that loss Gα(olf) function may also disrupt G 1 -S cell cycle control (48, 49) .
MATERIALS AND METHODS
Human subjects
Human studies were conducted in accordance with the Declaration of Helsinki, with formal approval from the institutional review boards at each participating study site. All genetic and phenotypic analysis and publication of the results were approved by the University of Tennessee Health Science Center Institutional Review Board (#01-07346-XP). Enrollment of patients with primary dystonia and neurologically-normal controls is described in previous publications (7, 12) . Genomic DNA was extracted from peripheral whole blood or saliva (Oragene DNA Self-Collection kit, DNA Genotek ® , Kanata, Ontario, Canada).
Exome sequencing and variant analysis
Three micrograms of genomic DNA from two affected and one control subject was sheared to yield 100-450 bp fragments. Sheared DNA was then subjected to Illumina paired-end library Table S10 ). After endogenous peroxidases were quenched, slides were blocked and exposed to the primary rabbit anti-GNAL antibody (1:100) overnight. After rinsing with PBS, slides were exposed to biotinylated goat anti-rabbit antibody (1:500) for 4 hrs, followed by rinsing and exposing to streptavidin for 1 hr. Labeling was visualized with nickel-intensified 3, Confluent cells (1 × 106 cells/ml) were harvested for RNA isolation. Ambion's TRI Reagent® was used to isolate RNA. The quality of total RNA derived from leukocytes and lymphoblastoid cell lines was accessed with a NanoDrop® ND-1000 spectrophotometer (NanoDrop Technologies), and Agilent 2100 Bioanalyzer using the Agilent RNA 6000 Nano Chip kit.
Gene expression studies
Total RNA from lymphoblastoid cell lines of eight subjects were processed on Illumina® 
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